164 related articles for article (PubMed ID: 31798706)
1. Comparison of urokinase and reteplase thrombolytic treatment in patients with high-risk pulmonary embolism.
Zhang Y; Ma L; Fu Q; Zhao T; Yan RY; Su X
Exp Ther Med; 2019 Dec; 18(6):4804-4810. PubMed ID: 31798706
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety comparison between pro-urokinase and reteplase in the treatment of patients with acute ST elevation myocardial infarction].
Zhang Y; Wang S; Gao CY; Liu XY; Cheng QQ; Zhang JH; Qi DD; Wang XP; Zhu ZY; Li MW; Hu DY
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Sep; 49(9):866-872. PubMed ID: 34530593
[No Abstract] [Full Text] [Related]
3. [Clinical efficacy and safety of thrombolytic treatment with reteplase in patients with intermediate-risk acute pulmonary embolism].
Zhao HG; Wang SX; Lu ZN; Yan XX; Lyu ZC; Peng FH; Wu Y; Gao X; Hua L; Jing ZC; Xu XQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Apr; 45(4):314-317. PubMed ID: 28545283
[No Abstract] [Full Text] [Related]
4. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism.
Tebbe U; Graf A; Kamke W; Zahn R; Forycki F; Kratzsch G; Berg G
Am Heart J; 1999 Jul; 138(1 Pt 1):39-44. PubMed ID: 10385761
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect evaluation of reteplase on acute pulmonary embolism.
Wang W; Zhao X; Ren Y; Qiao P
Pak J Pharm Sci; 2018 May; 31(3):899-905. PubMed ID: 29716871
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of thrombolytic therapy using reteplase in cases with acute ST-segment elevation myocardial infarction: results from a multicenter clinical trial].
Liu XY; Zhang Y; Li MW; Wang XP; Qi DD; Hao PY; Zhang H; Cheng QQ; Zhao LS; Gao CY; Hu DY
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):766-770. PubMed ID: 27667274
[No Abstract] [Full Text] [Related]
7. Intrapulmonary artery infusion of urokinase for treatment of massive pulmonary embolism: a review of 26 patients with and without contraindications to systemic thrombolytic therapy.
McCotter CJ; Chiang KS; Fearrington EL
Clin Cardiol; 1999 Oct; 22(10):661-4. PubMed ID: 10526692
[TBL] [Abstract][Full Text] [Related]
8. Safety of thrombolytic therapy in elderly patients with massive pulmonary embolism: a comparison with nonelderly patients.
Meneveau N; Bassand JP; Schiele F; Bouras Y; Anguenot T; Bernard Y; Schultz R
J Am Coll Cardiol; 1993 Oct; 22(4):1075-9. PubMed ID: 8409043
[TBL] [Abstract][Full Text] [Related]
9. Reteplase: a review of its use in the management of thrombotic occlusive disorders.
Simpson D; Siddiqui MA; Scott LJ; Hilleman DE
Am J Cardiovasc Drugs; 2006; 6(4):265-85. PubMed ID: 16913828
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of curative effect and thrombolysis time between r-tPA application and urokinase in the interventional thrombectomy and thrombolysis for acute and severe pulmonary embolism].
Feng QC; Li X; Dong GX; Fu J; Wang CM
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):460-3. PubMed ID: 24943029
[TBL] [Abstract][Full Text] [Related]
11. Thrombolytic therapy for acute pulmonary embolism.
Tapson VF
Semin Thromb Hemost; 2013 Jun; 39(4):452-8. PubMed ID: 23539415
[TBL] [Abstract][Full Text] [Related]
12. Thrombolytic therapy with urokinase for pulmonary embolism in patients with stable hemodynamics.
Zhang Y; Sun T; He B; Wang L
Med Sci Monit; 2007 Jan; 13(1):CR20-3. PubMed ID: 17179905
[TBL] [Abstract][Full Text] [Related]
13. [Biohumoral markers and right ventricular dysfunction in acute pulmonary embolism: the answer to thrombolytic therapy].
Enea I; Ceparano G; Mazzarella G; Di Sarno R; Cangiano G; Busino CA
Ital Heart J Suppl; 2004 Jan; 5(1):29-35. PubMed ID: 15253142
[TBL] [Abstract][Full Text] [Related]
14. Use of reteplase for thrombolysis in patients with massive pulmonary embolism diagnosed by bedside transthoracic echocardiography: A retrospective study of safety and efficacy.
Verma B; Singh AK
J Family Med Prim Care; 2019 Oct; 8(10):3155-3159. PubMed ID: 31742135
[TBL] [Abstract][Full Text] [Related]
15. Spotlight on reteplase in thrombotic occlusive disorders.
Simpson D; Siddiqui MA; Scott LJ; Hilleman DE
BioDrugs; 2007; 21(1):65-8. PubMed ID: 17263591
[TBL] [Abstract][Full Text] [Related]
16. Effect of reteplase on hemostasis variables: analysis of fibrin specificity, relation to bleeding complications and coronary patency.
Meierhenrich R; Carlsson J; Seifried E; Pfarr E; Smolarz A; Neuhaus KL; Tebbe U
Int J Cardiol; 1998 Jun; 65(1):57-63. PubMed ID: 9699932
[TBL] [Abstract][Full Text] [Related]
17. The Efficacy and Safety of Intermittent Low-Dose Urokinase Thrombolysis for the Treatment of Senile Acute Intermediate-High-Risk Pulmonary Embolism: A Pilot Trial.
Zhao T; Ni J; Hu X; Wang Y; Du X
Clin Appl Thromb Hemost; 2018 Oct; 24(7):1067-1072. PubMed ID: 29552916
[TBL] [Abstract][Full Text] [Related]
18. Update on Thrombolytic Therapy in Acute Pulmonary Thromboembolism.
Ucar EY
Eurasian J Med; 2019 Jun; 51(2):186-190. PubMed ID: 31258361
[TBL] [Abstract][Full Text] [Related]
19. [Multicenter clinical trial on the efficacy of thrombolytic therapy with urokinase and/or anticoagulant with low molecular weight heparin in acute pulmonary embolism].
Cheng X; He J; Gao M; Chen G; Li S; Zhang Z; Zhao M; Zhou S; Zhao J; Cheng L; Zhang Z; Chen Y; Xiong C
Zhonghua Nei Ke Za Zhi; 2002 Jan; 41(1):6-10. PubMed ID: 11940288
[TBL] [Abstract][Full Text] [Related]
20. An in vitro comparative study on clot lysis efficiency of urokinase and reteplase with the synergy of ultrasound needle.
Tang J; Tang J; Liao Y; Bai L; Luo T; Xu Y; Liu Z
Heliyon; 2024 Mar; 10(5):e26624. PubMed ID: 38463819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
